Cargando…
Ticagrelor-Induced Syncope/Bradyarrhythmia
Ticagrelor (BRILINTA®) is a very commonly used oral antiplatelet agent in acute coronary syndrome and after percutaneous coronary intervention (PCI). It is a reversible, direct inhibitor of the adenosine diphosphate (ADP) P2Y12 receptor. Most of the patients tolerate the drug well but it is known to...
Autores principales: | Kotaru, VeeraPavan, Kalavakunta, Jagadeesh K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899257/ https://www.ncbi.nlm.nih.gov/pubmed/33633903 http://dx.doi.org/10.7759/cureus.12874 |
Ejemplares similares
-
Melanoma With Cardiac Metastasis
por: Kotaru, Sruthi L, et al.
Publicado: (2023) -
Bradyarrhythmia in COVID-19 Patients
por: Hakami, Abdulrahman, et al.
Publicado: (2021) -
Large Saphenous Venous Graft Aneurysm with Right Atrial Fistulous Communication: Case Report and Review of Literature
por: Agrawal, Yashwant, et al.
Publicado: (2016) -
Right atrial mass‐multimodality imaging—Massive lipomatous hypertrophy of the atrial septum
por: Kotaru, Veera Pavan K., et al.
Publicado: (2020) -
Violent Hiccups: An Infrequent Cause of Bradyarrhythmias
por: Suh, William M., et al.
Publicado: (2009)